Esperion Therapeutics, Inc. revenue breakdown overview

Esperion Therapeutics, Inc. revenue for the last year amounted to 116.33 M USD, the most of which — 116.33 M USD — came from its highest performing source at the moment, Therapies, the year earlier bringing 75.47 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Esperion Therapeutics, Inc. 116.33 M USD, and the year before that — 75.47 M USD.